Lily Wu

Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.

Interrogating androgen receptor function in recurrent prostate cancer.

Integrated, molecular engineering approaches to develop prostate cancer gene therapy.

Transcriptionally targeted gene therapy to detect and treat cancer.

Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.

Applications of molecular imaging in cancer gene therapy.

Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction.

The current state of preclinical prostate cancer animal models.

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.

Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.

Non-invasive molecular imaging of prostate cancer lymph node metastasis.

Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.

Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice.

Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.

Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.

Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.

Chapter five--The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities.

CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer.

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.

Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.

A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.

Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.

Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.

Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.

Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.

Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.

Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma.